Article
Can I Transfer Priority Rights In China Without The Consent Of Other Applicants? Insights From The Broad Institute's CRISPR Patent
The high-profile disputes surrounding an important CRISPR patent belonging to The Broad Institute, MIT and Harvard (hereinafter "the proprietors") has attracted a lot of attention in recent years, particularly regarding the validity of priority rights that were challenged worldwide.
Eagle IP